Read news on Tirzepatide with our app.
Read more in the app
Tirzepatide can produce clinically meaningful - EurekAlert!
3-year study of tirzepatide shows that most patients only gain 5% or less from their lowest or ‘nadir’ weight - EurekAlert!
Cardiovascular and renal biomarkers in overweight and obese adults with type 1 diabetes treated with tirzepatide - EurekAlert
Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults - EurekAlert
Tirzepatide shows powerful diabetes-prevention effect in three-year trial
Can You Finally Throw Away Your CPAP Machine? Tirzepatide Offers Hope
Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain
